Change in Directorate
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors at their meeting held on 27th May, 2017, appointed Mr.P.R. Rangaswami (DIN:00151640) as an Alternate Director (Non- Executive Non Independent) to Kavetha Sundaramoorthy (DIN: 02050806) with immediate effect. Board approves Dividend
In accordance with the Regulation 30 read with Part A of Schedule III and Regulation 43 of SEBI (Listing Obligations and Disclosure Requirements, 2015, Board of Directors has recommended a final dividend of Re. 0.50 (i.e. @ 5%) per equity share of Rs. 10/- each fully paid up of the Company for the financial year 2016-17 subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The final dividend would be paid... Outcome of Board Meeting
In accordance with the Regulation 30 read with Part A of Schedule III and Regulation 43 of SEBI (Listing Obligations and Disclosure Requirements, 2015, Board of Directors has recommended a final dividend of Re. 0.50 (i.e. @ 5%) per equity share of Rs. 10/- each fully paid up of the Company for the financial year 2016-17 subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The final dividend would be paid... Board recommends Final Dividend
Lotus Eye Care Hospital Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2017, inter alia, has recommended a final dividend of Re. 0.50 (i.e. @ 5%) per equity share of Rs. 10/- each fully paid up of the Company for the financial year 2016-17 subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The final dividend would be paid within 30 days from the date of its declaration at the AGM. Outcome Of Board Meeting And Disclosure(S) Pursuant To Regulation 30
This is to inform you that the Board of Directors at their meeting held on 27th May, 2017 has inter-alia noted and approved the following: 1.Audited Financial Results Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, please find enclosed herewith the follwing: I.Audited Financial Results for the quarter/year ended 31st March, 2017;... Board to consider Final Dividend
Lotus Eye Care Hospital Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on May 27, 2017, to consider recommendation of dividend for the financial year ended on March 31, 2017, if any, subject to approval of the Members at the ensuing Annual General Meeting of the Company. Board to consider Dividend
Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby give prior intimation that a Meeting of the Board of Directors of the Company will be held on Saturday, the 27th Day of May, 2017 at the registered office at 770/12, Avinashi Road, Civil Aerodrome, Coimbatore - 641014, to consider recommendation of dividend for the financial year ended on 31st March, 2017, if any, subject to approval... Closure of Trading Window
Trading Window, in terms of Code of Conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015, shall remain closed for all the Designated Person(s) (including their Immediate Relative) from 16th May, 2017 to 30th May, 2017 (both days inclusive). Board Meeting On 27Th May, 2017
Pursuant to regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby give prior intimation that a Meeting of the Board of Directors of the Company will be held on Saturday, the 27th Day of May, 2017 at the registered office at 770/12, Avinashi Road, Civil Aerodrome, Coimbatore - 641014, to consider the following: 1. Audited Financial Results for the Quarter/Year ended 31st March, 2017; 2.Any other... Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kaliannagounder Sundaramoorthy